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Abstract
Involuntary movements as seen in repetitive disorders such as Tourette Syndrome (TS) results from cortical
hyperexcitability that arise due to striato-thalamo-cortical circuit (STC) imbalance. Transcranial direct current
stimulation (tDCS) is a stimulation procedure that changes cortical excitability, yet its relevance in repetitive disorders
such as TS remains largely unexplored. Here, we employed the dopamine transporter-overexpressing (DAT-tg) rat
model to investigate behavioral and neurobiological effects of frontal tDCS. The outcome of tDCS was pathology
dependent, as anodal tDCS decreased repetitive behavior in the DAT-tg rats yet increased it in wild-type (wt) rats.
Extensive deep brain stimulation (DBS) application and computational modeling assigned the response in DAT-tg rats
to the sensorimotor pathway. Neurobiological assessment revealed cortical activity changes and increase in striatal
inhibitory properties in the DAT-tg rats. Our findings show that tDCS reduces repetitive behavior in the DAT-tg rat
through modulation of the sensorimotor STC circuit. This sets the stage for further investigating the usage of tDCS in
repetitive disorders such as TS.
Introduction
Repetitive symptoms as observed in among others
Tourette Syndrome (TS) can in severe cases hinder social
and professional development1, 2. The pathology under-
lying the manifestation of repetitive symptomatology
remains inconclusive, yet vast evidence points to an
imbalanced striato-thalamo-cortical circuit (STC), where
a combined action of dopaminergic hyperresponsivity and
striatal disinhibition results in cortical hyperexcitability
and ultimately impaired movement control3–7.
Current drug therapies, especially those applied for
repetitive symptoms seen in TS, lack precision, which may
account for their inability to provide sufficient and
enduring symptom relief. One treatment strategy allowing
for focal intervention is deep brain stimulation (DBS) in
which electrical stimulation is delivered directly to
pathology-relevant brain areas through implanted elec-
trodes8. DBS has already been applied to several brain
structures within the STC circuit to reduce repetitive
behavior as seen in TS9–12. However, despite positive
results, its invasive nature hinders a general application
and is therefore mostly considered for only severely
affected adult patients13, 14. To increase the treatment
options for repetitive disorders, there is the need for more
subtle strategies suitable for a broader patient group.
Transcranial direct current stimulation (tDCS) is a non-
invasive, safe and well-tolerated strategy that modulates
cortical excitability through application of weak electrical
current. The effect on excitability depends on stimulation
polarity, with cathodal stimulation decreasing and anodal
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stimulation increasing membrane excitability at the
macroscopic level15–21. Beyond acute effects, prolonged
stimulation results in neuroplastic after effects, which
share some similarities with long-term potentiation and
depression15, 17, 22. tDCS has already been applied in
depression23, chronic pain24 and schizophrenia25, 26 with
so far largely positive results. Only one study documents
the usage of cathodal tDCS as a mean to reduce cortical
hyperexcitability and thus repetitive behavior in TS27.
Results seem promising, yet a thorough evaluation of its
therapeutic relevance in repetitive disorders is missing.
Still outstanding is an investigation on the preferable
current intensity and stimulation polarity for repetitive
pathology and subsequent symptoms. Obviously, such in-
depth assessment is clinically challenging, yet is overcome
preclinically by employing validated animal models.
The dopamine transporter-overexpressing (DAT-tg) rat
model exhibits multiple neurobiological abnormalities
considered to underlie repetitive disorders, including TS.
Apart from far-reaching dopaminergic alterations, these
include decrease in striatal GABAergic PV+ expressing
interneurons and increased c-fos levels in cortical areas,
demonstrating the existence of an imbalanced STC circuit
in this model also seen in TS. On a behavioral level,
DAT-tg rats display amphetamine sensitivity and sub-
sequent repetitive behavior that specifically responds to
TS-drug treatment, i.e. administration of the α2 adre-
nergic and imidazoline receptor agonist clonidine. The
occurrence of repetitive behavior in the DAT-tg rat is time
locked, which allows for evaluation of therapeutic inter-
ventions when behavioral manifestation is proven to be
most prominent28.
In this study, we sought to investigate the effects of
frontal tDCS on repetitive behavior in the DAT-tg rat.
Combining extensive DBS application alongside compu-
tational modeling of current spread we sought to identify
the sub-circuitry involved in the therapeutic response.
Finally, neurobiological assessment of the most ther-
apeutically potent tDCS application enabled mechanistic
insight into cortical activity patterns, neurotransmitter
levels and inhibitory properties of the striatum. Taken
together, our study provides a thorough investigation into




Experiments were performed in accordance to the
European Communities Council Directive of 22 Septem-
ber 2010 (2010/63/EU) after approval by the local ethics
committees (Senate of Berlin, Regierungspräsidium
Dresden). Experiments were conducted on male Wistar
DAT-tg rats (n= 38) and their respective littermate con-
trols (wild types (wt) (n= 37) with a Sprague Dawley
background once they reached postnatal day (PND)
>9028. Following surgery, animals were single housed in a
12 h light/dark cycle (light on at 06:00 am) with food and
water ad libitum. All efforts were made to reduce animal
suffering and number of animals used.
Experimental design
In this study, the experimental groups consisted of
subjects randomly allocated to the tDCS or DBS groups,
prior to surgeries. Animals ordained to receive tDCS
following surgery were subdivided into the tDCS group
(DAT-tg, n= 9,wt n= 7) and an overall control group
(DAT-tg, n= 8,wt n= 8). Common for all animals was the
implementation of an epicranial electrode, surgically fixed
onto the scull over the frontal cortex, through which
tDCS/sham stimulation was applied. Animals ordained to
receive DBS were subdivided into three groups (groups
1–3) prior to surgery and subsequently implanted bilat-
erally with monopolar electrodes into cortical and sub-
cortical areas of the STC circuit. These included the
orbitofrontal cortex (OFC) and caudate putamen (CPu)
(group 1) (DAT-tg, n= 8,wt n= 8), the medial prefrontal
cortex (mPFC) (group 2) (DAT-tg, n= 8,wt n= 8) or the
primary motor cortex (M1) and thalamus (Thal) (group 3)
(DAT-tg, n= 5,wt n= 6). All animals recovered for 1 week
after surgery before starting experiments. Animals in the
tDCS group received either sham, cathodal (100 or 200
µA) or anodal (100, 200 or 300 µA) stimulation. Animals
in the DBS group (groups 1–3) received either sham, high
(130 Hz) or low (10 Hz) frequency stimulation in the
respective brain areas. Animals in the control group only
received sham stimulation (see SI, Table S1 for overview
of group specifics and number of animals). The repetitive
behavioral paradigm described by Hadar et al.28 was
employed to study the effect of tDCS and DBS on beha-
vior. Stimulation was applied in the beginning of the
paradigm and subsequent behavior was assessed during
the stereotypy phase. Experiments were conducted in a
crossover design and different types of stimulation were
applied in a randomized fashion over the course of the
experiment. Animals could rest for 1 week in between
stimulation. Rats in the control group, receiving sham
stimulation, only went through the behavioral paradigm
once. These rats served as an overall control group for
later neurobiological assessment. For finalization of the
experiment, animals were stimulated with the most
therapeutic-relevant stimulation settings as assessed by
behavioral analysis. As such, animals in the tDCS group
received anodal 200 µA stimulation. Following the finali-
zation of the last experimental round, animals were
immediately sacrificed and brains were snap frozen for
later post mortem neurobiological assessment. Compu-
tational modeling was constructed to investigate the
electrical current spread mediated by tDCS. The
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investigators who run the analysis were blind to the group
allocation as well as when analyzing the data. More details
are included in the supplementary information.
Surgery
Animals went through surgery after reaching PND 90
(body weight of >280 g). Animals were handled 3–4 days
prior to surgery. Surgery was performed under sub-
cutaneous (s.c.) general anesthesia: fentanyl (0.005mg/
kg), midazolam (2 mg/kg) and medetomidine dihy-
drochloride (0.135 mg/kg). The scull was fixed in a ste-
reotactic frame and bregma was exposed. For animals in
the tDCS and control group, an epicranial electrode (2.1
mm diameter) composed of a tubular plastic jacket was
placed over the left frontal cortex (AP +3.2; ML1.5) and
fixed using glass inomer cement (Ketac Cem; ESPE Dental
AG, Seefeld, Germany). For DBS application, monopolar
electrodes (0.5 mm, MS303-6-AIU, Plastics One Inc.,
USA) were implanted bilaterally into the OFC (AP +3.7;
ML +2.4; DV –3.3), CPu (AP +1.5; ML +1.5; DV –4.0),
mPFC (AP +3.5; ML +0.6; DV –3.4), M1 (AP+ 1.5; ML
+2.7; DV –1.5) and Thal (AP –4.1; ML +1.3; DV –6.4).
Anchor screws were drilled into the scull for fixation and
the individual ground electrode from each DBS electrode
was wrapped around the closest screw and fixed with
dental cement (Technovit, Heraeus Kulzer GmbH,
Wehrheim, Germany). All coordinates were in accordance
to Paxinos rat brain atlas29. Upon completion of surgery,
anesthesia was antagonized by a cocktail of naloxone
(0.12 mg/kg), flumazenil (0.2 mg/kg) and antipamzol
(0.75 mg/kg). Analgesia (meloxicam: 0.2 mg/kg, s.c.) was
given for 3 days following surgery.
Repetitive behavior paradigm
As identified by Hadar et al.,28 DAT-tg rats display a
time-locked induction of repetitive behavior following
the injection of amphetamine. In this experiment, ani-
mals were injected with amphetamine (2.0 mg/kg, i.p.,
dissolved in 0.9% saline at a volume of 1.0 ml/kg, Sigma
Aldrich, Germany) and thereafter immediately subjected
to stimulation (either tDCS or DBS). Animals in the DBS
group received 60 min of stimulation. Cables were
removed following DBS application and the animals
could move freely for additional 60 min. Animals in the
tDCS conditions received 30 min of tDCS or sham sti-
mulation, respectively. Cables and jackets were removed
following tDCS application and the animals could move
freely for an additional 90 min (See SI, Figure S1).
Behavior was recorded via web cameras throughout the
paradigm. The occurrence of repetitive behavior (oral
stereotopy or head movements) was later analyzed dur-
ing the stereotopy phase (90–120 min following injec-
tion) by a blinded observer using the scoring protocol of
Hadar et al.28
tDCS application
For delivery of tDCS, the epicranial electrode was filled
with saline (0.9%) (contact area of 3.5 cm2) after which a
gold pin was inserted for stimulation application. A
counter electrode (8 cm2; From Physiomed Elek-
tromedizin AG, Schnaittach, Germany) was placed onto
the thorax together with electroencephalography (EEG)
conducting crème (GVB-geliMED KG, Germany) and
kept in place by a jacket30, 31. Animals were exposed to
either 30 min anodal (100, 200 or 300 µA), cathodal (100
or 200 µA) or sham stimulation in the beginning of the
repetitive behavioral paradigm. Both cathodal and anodal
stimulation were applied by a computer-interfaced cur-
rent generator (STG4008 Multi Channel System GmbH
Reutlingen, Germany). The current strength was ramped
for 10 s to prevent abrupt interruption and stimulation
break effects. For sham stimulation, animals were con-
nected to the system, yet no current was flowing.
DBS application
DBS was applied as biphasic 100 μs pulses with either a
current intensity of 150 μA and frequency of 130 Hz (high
frequency) or with a current intensity of 300 μA and fre-
quency of 10 Hz (low frequency). Stimulation was con-
trolled by the STG4008 Multi Channel System GmbH
Reutlingen, Germany. At 1 day prior to testing, DBS or
sham stimulation was performed twice for 1 h (morning
and afternoon). On testing day, animals were subjected to
60min of either high- or low-frequency stimulation in the
respective areas during the beginning of the behavioral
paradigm. Sham stimulation was applied in an identical
fashion yet no current was flowing.
Post mortem neurobiological assessment
Decapitation and snap freeze
Animals were immediately sacrificed following finali-
zation of the experiment. Brains were extracted within
less than 20 s, snap frozen for 2 min in methylbutane
cooled with liquid nitrogen to a temperature of −40 °C
and then stored at −80 °C until required. Next to elec-
trode localization, frozen coronal sections of 1 or 0.5 mm
were cut on a cryostate (see Table S2 for coordinates).
High-performance liquid chromatography (HPLC)
Tissue samples were taken via micropunches of 1 mm
diameter and were homogenized by ultrasonication in
250 µl (per punch) 0.1 N perchloric acid at 4 °C. Then,
100 µl of the homogenate was added to equal volumes of
1N sodium hydroxide for measurement of protein con-
tent. The remaining homogenate was centrifuged at
13,000 g and 4 °C for 15min. The supernatant was added
to equal volumes (20 µl) of 0.5M borate buffer and stored
at −80 °C for subsequent analyses of amino acids. The
remaining supernatant was used for immediate
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measurement of monoamines. Monoamine levels (3,4-
dihydroxyphenylacetic acid (DOPAC) and dopamine
(DA)) were measured by HPLC with electrochemical
detection as previously described32, 33.
Quantitative polymerase chain reaction (qPCR)
Tissue samples from the left hemisphere were taken via
micropunches of 1 mm diameter from the mPFC, M1 and
OFC. Further tissue samples were taken in the same way
from both hemispheres from the CPu. Tissue was
homogenized by ultrasonication in the buffer provided by
the NucleoSpin RNA/Protein-Kit (Machery-Nagel,
Düven, Germany). The total RNA and protein was
extracted as recommended in its user manual. RNA
concentrations were determined using a Nanodrop
Spectrophotometer (peqlab). cDNA was synthesized using
the High Capacity RNA-to-cDNA Kit (Lifetechnologies).
TaqMan qPCR was performed with StepOne Real-Time
PCR System (Lifetechnologies) using TaqMan fast
advanced master mix (Lifetechnologies). The following
TaqMan Gene Expression assays (Lifetechnologies) were
used: Pvalb Assay (Rn00574541_m1) and c-Fos Assay
(Mm00487425_m1). CT values were normalized to the
housekeeping gene GFAP (Rn01253033_m1). Fold change
was calculated using the ΔΔCT method.
Electrode localization
At the respective coordinates, brains were sliced into 20
mm coronal sections and Nissl-stained for light micro-
scopic inspection of electrode tip placements as pre-
viously explained34–36. One animal with a wrong-
positioned electrode was excluded from the study.
Computational modeling
To determine the effect of various current densities on
the cortex, a state-of-the-art model was constructed from
a magnetic resonance imaging (MRI; 7.0 Tesla70/30
Bruker Biospec) and micro computed tomography scan
(Siemens Inveon) of a template rat head37.
MRI data collection and segmentation
MRI resolution was 0.282 mm, as previously men-
tioned37. The scans were segmented into 9 tissues: skin,
skull, cerebral spinal fluid (CSF), air, gray matter, white
matter, hippocampus, cerebellum and spinal cord. A Rat
Brain Atlas38 was used to identify the hippocampal region
of the brain. Remaining brain regions were appropriately
grouped as either gray or white matter. Manual segmen-
tation was used to generate an initial segmentation of
scalp, skin, CSF, air, gray matter, white matter, hippo-
campus, cerebellum and spinal cord. Tissue continuity
was verified after segmentation by extensively reviewing
the data. Further manual adjustments were made to
guarantee continuity and improve the segmentation
accuracy to closely match the tissue masks to the real
anatomy of the rodent using ScapIP 7.0 (Simpleware Ltd,
Exeter, UK).
Modeling of tDCS
The tDCS in vivo electrode placement protocol descri-
bed above was modeled in SolidWorks (Dassault Sysemes
Corp. Waltham, MA) and imported into ScanIP for
meshing. The modeled epicranial electrode had a contact
area of 3.5 cm2 and was placed in accordance to coordi-
nates used in the behavioral experiment (AP: +3.2;
ML:1.5). The 1.0 mm diameter gold pin serving as the
anode was placed on the skull inside of the epicranial
electrode. An 8 cm2 cathode was placed on the thorax
with EEG conducting crème as an electrolyte. An adaptive
tetrahedral meshing algorithm was used in ScanIP to
generate meshes of 8× 106 quadratic elements. A Finite
Element Method (FEM) model was created in COMSOL
Multiphysics 4.3 (COMSOL, Inc., Burlington, MA) using
the mesh mentioned above. The model was created using
electrostatic volume conductor physics with material
conductivities defined as follows (in S/m): skin, 0.465;
skull, 0.01; CSF, 1.65; air, 1e−15; spinal cord, 0.126; gray
matter, 0.276; white matter, 0.126; hippocampus, 0.126;
cerebellum, 0.276; dental cement, 1e−15; electrode jacket,
1e−15; saline, 1.4; and electrode, 5.99e7. Conductivity
values were taken from a combination of in vitro and
in vivo measurements39, 40. Current boundaries were
applied to simulate direct current stimulation, and inter-
nal boundaries between tissues were assigned the con-
tinuity condition (n * (J1−J2)= 0), and the Laplace
equation (∇ ∗ (σ∇V)= 0) was solved. The surface of the
cathode was grounded (V= 0) while the surface of the
anode had a current density of 3.252e−4 A/m2. All other
exterior surfaces were electrically insulated. Brain current
density data were collected from the left cortical hemi-
sphere above the corpus callosum and averaged for ana-
lysis. High-resolution models predicted the concentration
and distribution of brain current density for the in vivo
rodent model using the electrode montage.
Statistics
Sample size was chosen based on the convention that
for behavioral experiments n of 8–10 ensures adequate
power to detect a prespecified effect size and on our
previous experience with the chosen methods28. Inclusion
criterion was the complete endurance of the neuromo-
dulation period. This criterion is an integral part of the
study objectives and design as it was designed to study
DBS as a preventive avenue. Exclusion criterion for out-
liers was +/−2 standard deviations of the means. Beha-
vioral analysis was performed using a one-way analysis of
variance (ANOVA) repeated measure with Treatment as
variables. Post-hoc tests utilized the Holm–Sidak for
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multiple comparisons. Neurobiological analysis for HPLC
was performed using a two-Way ANOVA with treatment
(sham, tDCS and DBS) and phenotype (DAT-tg vs. wt) as
variables. Analysis of qPCR data was conducted following
normalization to sham stimulation, with a one-way
ANOVA used for c-fos analysis and a non-parametric
Mann–Whitney test employed for parvalbumin (PV)
analysis. Statistical significance was set at p< 0.05. Results
are expressed as mean± s.e.m. The experiment shown
was replicated once in our lab.
Results
Behavioral effects
The after-effect of tDCS (anodal and cathodal) on
behavior was assessed during the stereotypy phase of a
repetitive paradigm28. In DAT-tg rats, one-way repeated
measure analysis of variance (rmANOVA) tDCS effects
on behavior in relation to sham revealed a significant
effect for treatment (F5,33= 2.727, p= 0.036), with a fur-
ther post-hoc test showing that frontal anodal tDCS at
200 µA significantly reduced oral stereotypy when com-
pared to sham stimulation (p= 0.012) (Fig. 1a). In wt rats,
one-way rmANOVA showed a significant effect for the
factor treatment (F5,28= 3.388, p= 0.016), with anodal
tDCS at 200 µA significantly increasing head movements
in comparison to sham stimulation (p= 0.015) (Fig. 1b),
whereas no effect of either anodal or cathodal tDCS was
seen on oral stereotypy (data not shown). The effect of
high- and low-frequency DBS was assessed following the
application to several cortical and subcortical structures.
In DAT-tg rats, one-way rmANOVA showed a significant
Fig. 1 The effects of tDCS and DBS on repetitive behavior. a tDCS (anodal/cathodal at 100 , 200 or 300 µA) effects on the occurrence of oral
stereotypy in the DAT-tg rats in relation to sham stimulation. b Effect of tDCS (anodal/cathodal at 100 , 200 or 300 µA) on the occurrence of head
movements in the wt rats in relation to sham stimulation. c Low- and high-frequency DBS (mPFC, OFC, M1, Thal and CPu) effects on the occurrence
of oral stereotypy in the DAT-tg rats in relation to sham stimulation. d Low- and high-frequency DBS (mPFC, OFC, M1, Thal and CPu) effects on the
occurrence of oral stereotypy in the wt rats in relation to sham. wt wild-type rats, DAT-tg dopamine transporter-overexpressing rats, mPFC medial
prefrontal cortex, OFC orbitofrontal cortex, M1 primary motor cortex, Thal thalamus, CPu caudate putamen. All data are given as mean ± s.e.m.
Asterisks (*) indicate significant differences between stimulation conditions with p < 0.05
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effect for treatment (F10,51= 4.112, p< 0.001), as oral
stereotypy significantly decreased following high-
frequency DBS to the CPu (p= 0.001) and M1 (p=
0.019) in comparison to sham stimulation. In contrast, no
effect was found following DBS to the mPFC, OFC or
thalamus (thal) at either low- or high-frequency stimula-
tion (Fig. 1c). In wt rats, a significant effect was found for
the factor treatment (F10,54= 4.102, p< 0.001), with an
increase in oral stereotypy seen after high-frequency DBS
to the OFC (p= 0.001) and CPu (p= 0.026) in compar-
ison to sham stimulation. No effect was seen following
DBS to the mPFC, M1 or thal at either low- or high-
frequency stimulation (Fig. 1d).
Activity measures
The current density resulting from anodal tDCS at 200
µA was predicted by computational modeling. Current
density distribution following anodal tDCS for the in vivo
rodent model is shown in Fig. 2c. Results show a promi-
nent peak of both average current density and average
power dissipation approximately 1.5 mm anterior to
bregma (average current density 1,18825E–06; average
power dissipation 2,0979E–11) (Fig. 2a, b). Analysis of c-
fos mRNA expression levels was conducted to quantify
cortical activity pattern following effective tDCS in rela-
tion to sham stimulation. A one-way ANOVA showed a
significant difference in the mPFC, (F1,13= 7.732,
Fig. 2 A realistic high-resolution MRI-based rat computational model and predicted average current density and power dissipation.
a Illustration of render of bone generated from images and segmented for the FEM model. b Electrode positioning on the entire model with
transparent skeleton, brain, spines and electrodes. The red pellet-shaped anode electrode and blue cathode electrode are positioned as
aforementioned. c Uniformly seeded streamlines from the top surface of the anode electrode that were proportional to the logarithm of current
density magnitude. Trajectories of the streamlines predict direct current flow across different brain tissues. d Predicted current density at the surface
of the brain and a slice view of the distribution showing peak current density during tDCS. Lowest brain current density values are represented in
blue, and greater brain current density values are represented in dark red. e Average current density across the cortex following anodal tDCS.
f Average power dissipation across the cortex following anodal tDCS. The dotted lines in both e, f illustrate the boundary of the electrode in
accordance to bregma
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p= 0.016) and OFC (F1,10= 5.129, p= 0.043) such that
within these areas anodal tDCS at 200 µA significantly
increased c-fos mRNA levels in the DAT-tg rats. No
difference in c-fos levels was detected in the wt rats.
(Fig. 3).
Neurobiological assessment
Neurobiological investigations were conducted for
frontal anodal tDCS at 200 µA. HPLC post mortem bio-
chemical analysis was made to investigate the persisting
effect on neurotransmitter levels. Based on previously
proven relevance28, DA levels and DA turnover (DOPAC/
DA) were assessed in the OFC, CPu and NAcc. Looking at
DA levels, two-way ANOVA revealed a significant main
effect for phenotype in the OFC (F1,22= 5.270, p= 0.032),
CPu (F1,23= 247.623, p< 0.001) and NAcc (F1,23= 29.285
p< 0.001) with DAT-tg rats generally displaying lower DA
levels in comparison to wt rats (Fig. 4a–c, Table 1). Fur-
ther investigation into DA turnover revealed in the OFC,
CPu and NAcc a significant effect for phenotype (OFC:
F1,22= 37.471, p< 0.001; CPu: F1,23= 43.789, p< 0.001;
NAcc: F1,22= 45.293, p< 0.001), with DAT-tg rats show-
ing a higher degree of DA turnover as compared to the wt
rats (Fig. 4d–f, Table 1).
To quantify inhibitory properties of the striatum, a
qPCR on PV mRNA in the CPu was employed. The
Mann–Whitney test revealed a significant reduction in PV
mRNA levels following tDCS in the DAT-tg rats as
compared to sham stimulation (Mann–Whitney U=
1.500, p= 0.005). No difference was observed in the wt
rats. (Fig. 5). See Supplementary Information (SI) for
neurobiological assessment and computational modeling
of DBS application.
Discussion
Here, we demonstrate that anodal tDCS applied at 200
µA to the rat frontal cortex significantly reduced repetitive
behavior in the DAT-tg rat model. By mathematically
modeling current density distribution and multisite DBS
application, we further show that the tDCS-therapeutic
effects involved a modulation of the sensorimotor STC
circuit.
The cumulative outcome of tDCS relies on several
factors including stimulation intensity, duration and
polarity in combination with the initial neuronal baseline
activity, neurotransmitter profile and target structure
composition41–43. These interacting components all
challenge direct comparisons between studies and
demonstrate the need for specific assessment of tDCS
effects in a given disorder. Well-controlled studies in
appropriate animal models provide a platform for inves-
tigating interactions between the respective pathology and
stimulation parameters that ultimately will determine the
tDCS procedure needed for therapeutic relief. We found
repetitive behavior to significantly decrease in DAT-tg rats
following application of frontal anodal tDCS (200 µA),
whereas the same stimulation type increased it in wt rats.
Higher (300 µA) and lower (100 µA) current intensities
had no effect in either phenotype. In the context of
repetitive behavior, these results demonstrate a polarity-
specific and non-linear dose dependency of tDCS. DAT-tg
rats display heightened cortical activity levels due to an
underlying hyperresponsive dopaminergic system in
comparison to wt rats28. In line with this, it was previously
shown that alterations in the underlying dopaminergic
state, either pharmacologically induced or due to disease-
related alterations, could modify and even invert the
facilitating effects of tDCS44–48. As the final tDCS
response depends on initial cortical activity and under-
lying DA levels, the opposing behavioral outcome
between the two phenotypes further reflects a state-
dependent modulation of tDCS. Of note, repetitive
behavior observed in wt rats (i.e., head movements) fol-
lowing tDCS differed from that induced in DAT-tg rats
(oral stereotypy) further corroborating the notion of a
differential modulation mediated by tDCS in the two
phenotypes.
The STC circuit is composed of several topographically
organized pathways that are separately associated with
different aspects of repetitive symptomatology. The
Fig. 3 C-fos expression levels. Figure showing c-fos mRNA
expression levels in the mPFC, OFC and M1 in the DAT-tg and wt rats
following tDCS (anodal, 200 µA) in relation to sham. wt wild-type rats,
DAT-tg dopamine transporter-overexpressing rat, OFC orbitofrontal
cortex, M1 primary motor cortex, tDCS transcranial direct current
stimulation. All data are given as mean ± s.e.m. Asterisks (*) indicate
significant difference between stimulation with p < 0.05
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Fig. 4 Dopamine levels. Figure showing dopamine content (µM/g protein) in the a OFC b CPu and c NAcc following sham and tDCS (anodal, 200
µA) and dopamine turnover (DOPAC/DA) (µM/g protein) in the d OFC e CPu and f NAcc following sham and tDCS (anodal, 200 µA). wt: wild-type rats,
DAT-tg dopamine transporter-overexpressing rat, DA dopamine, DOPAC 3,4-Dihydroxyphenylacetic acid, OFC orbitofrontal cortex, CPu caudate
putamen, NAcc nucleus accumbens, tDCS transcranial direct current stimulation. All data are given as mean ± s.e.m. Asterisks (*) indicate significant
difference between stimulation protocols, and the symbol (§) indicates significant differences between phenotype with p < 0.05
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sensorimotor circuit is considered the site of tic origin,
whereas the limbic and associative circuits are linked to
comorbidity and cognitive deficiency49, 50. To further
identify the sub-circuit involved in modulation of repeti-
tive behavior in DAT-tg rats by tDCS, we applied DBS to
several cortical and subcortical areas of the STC circuit.
On a cortical level, repetitive behavior significantly
decreased in DAT-tg rats when stimulating the primary
motor cortex (M1). Contrary, repetitive behavior in DAT-
tg rats was not affected when DBS was applied to the
mPFC or OFC. This indicates that modulation of sen-
sorimotor pathways is essential for improving movement
control in DAT-tg rats, a notion that is further corrobo-
rated by our findings showing that also DBS of the CPu
but not the Thal decreased repetitive behavior in DAT-tg
rats. Of note, DBS modeling identified maximum current
density to subside especially within the M1 and CPu fol-
lowing high-frequency DBS, indicating elevated suscept-
ibility of these regions to stimulation (see SI, Figure S5).
High-frequency DBS has, as opposed to low-frequency
DBS and sham stimulation, proven capable of modulating
widespread neuronal circuits, which subsequently has
been linked to its therapeutic effect51. In correlation,
repetitive behavior only decreased in DAT-tg rats fol-
lowing high-frequency DBS, whereas the effect of low-
frequency DBS was equivalent to sham stimulation.
Indeed, tic generation has been often linked to abnormal
motor cortex excitability, with a subsequent modulation of
the M1 needed for therapeutic relief27, 52–58. Frontal
anodal tDCS applied in this study ultimately targets
Table 1 Neurotransmitter contents
Region Transmitter Pheno Stim µM/g protein Two-way
ANOVA
DF F-value P-value
DA wt sham 23.185±4.319 Pheno (1,22) 5.27 0.032a
OFC tDCS 15.630±4.731 Stim (1,22) 2.82 0.107
DAT-tg sham 13.034±3.740 Interaction (1,22) 0.0129 0.911
tDCS 6.435±3.999
DOPAC wt sham 0.257±0.266 Pheno (1,21) 37.471 <0.001a
tDCS 0.194±0.291 Stim (1,21) 4.243 0.052
DAT-tg sham 2.353±0.230 Interaction (1,21) 3.328 0.082
tDCS 1.328±0.266
DA wt sham 963.86±52.35 Pheno (1,23) 247.623 <0.001a
CPu tDCS 1002.0±61.95 Stim (1,23) 0.146 0.706
DAT-tg sham 129.65±48.97 Interaction (1,23) 0.105 0.749
tDCS 132.78±52.35
DOPAC wt sham 0.052±0.160 Pheno (1,23) 43.789 <0.001a
tDCS 0.052±0.190 Stim (1,23) 0.497 0.497
DAT-tg sham 1.264±0.150 Interaction (1,23) 0.495 0.495
tDCS 1.035±0.160
DA wt sham 398.19±40.73 Pheno (1,23) 29.285 <0.001a
Nacc tDCS 390.92±48.19 Stim (1,23) 0.0359 0.851
DAT-tg sham 171.01±38.11 Interaction (1,23) 0.00028 0.987
tDCS 162.32±40.74
DOPAC wt sham 0.090±0.038 Pheno (1,22) 45.293 <0.001a
tDCS 0.104±0.045 Stim (1,22) 0.372 0.548
DAT-tg sham 0.354±0.036 Interaction (1,22) 0.072 0.791
tDCS 0.390±0.041
OFCorbitofrontal cortex, NAcc nucleus accumbens
Neurochemical content was examined in the DAT-tg and wt rats following sham and tDCS. Dopamine levels and dopamine turnover were measured in the medial
OFC, NAcc and CPu. Data are presented as mean ± s.e.m. Asterisks (*) indicate significant differences between phenotype with p < 0.05
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multiple cortical areas, which hinders the ability to specify
the precise cortical region underlying the therapeutic
response. To further dissect cortical impact of anodal
tDCS, an individualized model of current distribution was
constructed. Despite uniform application, tDCS has shown
to produce a complex spatial pattern of current density
across cortical regions42. Indeed, variation in current
density was found across the cortex, with results revealing
a specific peak of average current density and power dis-
sipation over the coordinates matching the M1 target, of
which DBS exerted beneficial effects. Together, these
finding identify the motor cortex as a potential key region
for the therapeutic action of anodal tDCS.
Nevertheless, our data also show that M1 is not the only
cortical structure of relevance to repetitive behavior in
general and tics in particular but that both the OFC and
the mPFC also play a crucial role. Same as frontal anodal
tDCS, DBS applied to the OFC led to repetitive behavior
in wt rats, which underlines the involvement of the OFC
in the occurrence of repetitive behavior59–61. The
mechanism of action leading to this stimulation-induced
behavior in wt rats still remains to be elucidated. Further,
our data on c-Fos mRNA showed persistent activity in the
OFC and mPFC in DAT-tg rats after tDCS, whereas no
change was observed in the wt rats. A major proportion of
TS patients ultimately gain control over symptoms when
approaching adulthood62. The ability to voluntarily sup-
press tics has been linked to adaptive cortical changes, by
which a persistent, increased activity between frontal and
sensorimotor areas ultimately minimizes unwanted
movement execution. As opposed to healthy subjects, this
adaptive cortical interaction is continuously heightened in
TS and persists even during voluntary movement sup-
pression3, 54. In correlation, anodal tDCS has been shown
to induce compensatory cortical activity changes in Par-
kinson’s disease, which has been linked to the symptom
relief mediated by tDCS63, 64. The persistent cortical
activity observed after the end of anodal tDCS in the
DAT-tg rat leaves thought for further investigation into
how cortico–cortical interaction between the frontal and
sensorimotor cortices are modified by tDCS and thus
ultimately influences behavior in the DAT-tg rats.
Cortical hyperexcitability is considered a consequence
of underlying striatal disinhibition. In this regard, we
observed that CPu-DBS reduces repetitive behavior in
DAT-tg rats and increases it in wt rats. DBS is regarded as
being capable to induce functional inhibition of the sti-
mulated target, however preclinical studies show that DBS
effects are phenotype dependent and thus rely on the
underlying pathology34, 65–67. Hence, the induction of
repetitive behavior in wt rats following CPu-DBS may
reflect striatal silencing shown to drive repetitive beha-
vior, whereas the reduction in the DAT-tg rats indicates
the need for modifying the dysfunctional striatum to
improve symptoms.
Striatal disinhibition in TS is largely believed to origi-
nate from a loss of GABAergic PV+ expression inter-
neurons68, 69. This notion is further corroborated by
animal studies showing that repetitive behavior occurs in
both rodents and primates following striatal lesion but
also selective GABAergic pharmacological inactivation of
the striatum70–72. Identical to TS patients, DAT-tg rats
display a specific reduction of striatal PV+ expressing
interneurons28. In accordance to the translational
importance of striatal disinhibiton in both TS patients and
DAT-tg rats, we observed a general decrease in PV+
mRNA levels in the striatum following anodal tDCS.
Interestingly, PV+ mRNA expression levels and loss of
PV+ interneurons promote opposing effects on activity
balance, as decrease in mRNA levels enhances whereas
interneuron loss reduces inhibition, respectively73. In
accordance, studies investigating the role of PV+ in
synaptic transmission show that decrease in PV+
expression levels increase short-term facilitation of GABA
release, thus leading to increased inhibition73, 74. This
suggests that modulation of striatal activity properties is
involved in the reduction of repetitive behavior in the
DAT-tg rats. However, more studies are needed on this
matter including the investigation into how tDCS affects
mRNA turnover levels and how this translates into
expression of PV+ striatal interneurons. Of note, a sig-
nificant decrease in striatal PV mRNa levels was also
observed following application of therapeutic M1-DBS in
the DAT-tg rats, indicating a general proficiency of
M1 stimulation to affect the CPu (see SI, Figure S4).
Fig. 5 Parvalbumin mRNA levels in the caudate putamen. Figure
showing the Pv+ mRNA expression levels in CPu in the DAT-tg and wt
rats following tDCS (anodal, 200 µA) in relation to wt sham. wt wild-
type rats, DAT-tg dopamine transporter-overexpressing rat, Pv+
parvalbumin, CPu caudate putamen, tDCS transcranial direct current
stimulation, M1 primary motor cortex. All data are given as mean ± s.e.
m. Asterisks (*) indicate significant differences between stimulation
protocols with p < 0.05
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Moreover, it has been shown that only anodal tDCS but
not cathodal stimulation of the M1 can modulate sub-
cortical structures of the STC circuit74. Given that we did
not observe improvement in behavior following cathodal
stimulation at any intensity tested, we may speculate that
the therapeutic effect of anodal tDCS at least in part
depends on its ability to affect striatal inhibition reflected
in abnormal PV+ control.
The majority of literature supports the hypothesis of a
deregulated DA system in TS pathology. This notion is
supported by clinical findings as DA antagonists ameliorate
and DA stimulants exacerbate tics, respectively.75, 76 In
line, DAT-tg rats display a general decrease in DA levels
and increase in DA turnover due to DAT overexpression.
Our results show no effect of tDCS on either DA levels or
turnover, indicating that the therapeutic effect of tDCS
goes beyond the dopaminergic system. Of note, therapeutic
DBS led to modulation of the dopaminergic system in the
DAT-tg rats, which correlates with the mechanism of DBS
in TS patients (see SI, Figs. S2–S3 and Table S3)77.
Taken together, we find that tDCS reduces repetitive
behavior in the DAT-tg rats presumably through a
restoration of the previously imbalanced sensorimotor STC
circuit. Given the importance of the STC circuit in repe-
titive pathology, this indicates that tDCS may be employed
as stimulation approach to provide symptom relief for
repetitive disorders. From a clinical perspective, the pri-
mary motor cortex is the best-studied brain area with
respect to tDCS application. Based on the initial contra-
dicting line of reasoning, anodal tDCS to the motor cortex
has so far not been assessed as a mean to reduce cortical
excitability for treatment of, for example, TS. Yet, given the
underlying pathology found in repetitive disorders and in
TS, application of anodal tDCS might just have a positive
effect on repetitive behavior as indicated by our findings.
Our results thus set the stage for further investigation into
the therapeutic application of tDCS in repetitive disorders.
If successful, tDCS would provide a non-invasive and safe
treatment strategy suitable for patients at all age groups.
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